Diamond Hill Capital Management Inc Pfizer Inc Transaction History

Diamond Hill Capital Management Inc

$24.4 Billion
Q1 2024

A detailed history of Diamond Hill Capital Management Inc transactions in Pfizer Inc stock. As of the latest transaction made, Diamond Hill Capital Management Inc holds 16,106,012 shares of PFE stock, worth $451 Million. This represents 1.84% of its overall portfolio holdings.

Number of Shares

16,106,012

Previous 11,798,573 36.51%

Holding current value

$451 Million

Previous $340 Million 31.58%

% of portfolio

1.84%

Previous 1.5%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$25.89 - $29.73 $112 Million - $128 Million	4,307,439 Added 36.51%	16,106,012 $447 Million
Q4 2023 Feb 05, 2024	BUY	$26.13 - $33.94 $136 Million - $176 Million	5,194,844 Added 78.67%	11,798,573 $340 Million
Q3 2023 Nov 02, 2023	SELL	$32.09 - $37.51 $9.51 Million - $11.1 Million	-296,444 Reduced 4.3%	6,603,729 $219 Million
Q2 2023 Aug 08, 2023	BUY	$36.12 - $41.79 $4.74 Million - $5.49 Million	131,305 Added 1.94%	6,900,173 $253 Million
Q1 2023 May 11, 2023	SELL	$39.39 - $51.28 $1.2 Million - $1.56 Million	-30,443 Reduced 0.45%	6,768,868 $276 Million

Q4 2022 Feb 07, 2023	SELL	$41.75 - $54.5 $50 Million - $65.2 Million	-1,196,478 Reduced 14.96%	6,799,311 $349 Million
Q3 2022 Nov 08, 2022	SELL	$43.76 - $53.42 $48.9 Million - $59.7 Million	-1,117,441 Reduced 12.26%	7,995,789 $350 Million
Q2 2022 Aug 09, 2022	SELL	$46.53 - $55.17 $13.7 Million - $16.2 Million	-293,502 Reduced 3.12%	9,113,230 $478 Million
Q1 2022 May 11, 2022	SELL	$45.75 - $56.69 $18.9 Million - $23.5 Million	-413,679 Reduced 4.21%	9,406,732 $487 Million
Q4 2021 Feb 08, 2022	SELL	$41.32 - $61.25 $34.1 Million - $50.6 Million	-825,746 Reduced 7.76%	9,820,411 $580 Million
Q3 2021 Nov 15, 2021	SELL	$39.25 - $50.42 $40.6 Million - $52.2 Million	-1,035,221 Reduced 8.86%	10,646,157 $458 Million
Q2 2021 Aug 03, 2021	BUY	$35.91 - $40.68 $15.7 Million - $17.8 Million	438,427 Added 3.9%	11,681,378 $457 Million
Q1 2021 May 04, 2021	BUY	$33.49 - $37.77 $69.1 Million - $78 Million	2,064,225 Added 22.49%	11,242,951 $407 Million
Q4 2020 Feb 08, 2021	BUY	$33.47 - $42.56 $15.6 Million - $19.9 Million	467,368 Added 5.37%	9,178,726 $338 Million
Q3 2020 Nov 09, 2020	SELL	$31.75 - $37.25 $2.81 Million - $3.29 Million	-88,396 Reduced 1.0%	8,711,358 $320 Million
Q2 2020 Aug 10, 2020	BUY	$30.12 - $36.54 $1.9 Million - $2.31 Million	63,223 Added 0.72%	8,799,754 $288 Million
Q1 2020 May 05, 2020	BUY	$27.03 - $38.62 $16.4 Million - $23.4 Million	606,061 Added 7.45%	8,736,531 $285 Million
Q4 2019 Feb 07, 2020	SELL	$32.92 - $37.36 $3.89 Million - $4.42 Million	-118,232 Reduced 1.43%	8,130,470 $319 Million
Q3 2019 Oct 30, 2019	BUY	$32.49 - $42.13 $17.8 Million - $23 Million	546,541 Added 7.1%	8,248,702 $296 Million
Q2 2019 Aug 01, 2019	BUY	$36.98 - $41.52 $4.22 Million - $4.74 Million	114,064 Added 1.5%	7,702,161 $334 Million
Q1 2019 Apr 30, 2019	BUY	$37.5 - $41.2 $10.7 Million - $11.7 Million	284,683 Added 3.9%	7,588,097 $322 Million
Q4 2018 Feb 11, 2019	SELL	$38.47 - $43.86 $28.7 Million - $32.7 Million	-745,581 Reduced 9.26%	7,303,414 $319 Million
Q3 2018 Nov 13, 2018	SELL	$34.47 - $41.81 $17.5 Million - $21.2 Million	-507,041 Reduced 5.93%	8,048,995 $355 Million
Q2 2018 Aug 07, 2018	SELL	$32.98 - $35.16 $31.4 Million - $33.5 Million	-951,533 Reduced 10.01%	8,556,036 $310 Million
Q1 2018 May 02, 2018	SELL	$31.91 - $37.02 $44.7 Million - $51.9 Million	-1,401,534 Reduced 12.85%	9,507,569 $337 Million
Q4 2017 Feb 06, 2018	SELL	$33.26 - $35.29 $7.3 Million - $7.75 Million	-219,493 Reduced 1.97%	10,909,103 $395 Million
Q3 2017 Oct 18, 2017	BUY	$31.0 - $34.15 $345 Million - $380 Million	11,128,596	11,128,596 $397 Million

Others Institutions Holding PFE

# of Institutions

3,159

Shares Held

3.68B

Call Options Held

67.4M

Put Options Held

113M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $157B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Diamond Hill Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Diamond Hill Capital Management Inc with notifications on news.

Account

Diamond Hill Capital Management Inc Pfizer Inc Transaction History